Fulgent Genetics Inc (FLGT)

May 24, 2026

(FLGT) and the Role of Price-Sensitive Allocations - Stock Traders Daily

May 24, 2026

May 22, 2026

Law firm investigates Fulgent Genetics for possible securities law violations after revenue miss. - Pluang

May 22, 2026

May 22, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire

May 22, 2026

May 22, 2026

Fulgent Genetics Presents Promising Phase 2 FID-007 & Cetuximab Data for Head and Neck Cancer at ASCO 2026 - Minichart

May 22, 2026

May 22, 2026

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting - BioSpace

May 22, 2026

May 21, 2026

Fulgent reports interim data for cancer drug FID-007 trial By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

Fulgent reports interim data for cancer drug FID-007 trial - Investing.com

May 21, 2026

May 21, 2026

Fulgent Announces ASCO Rapid Oral Abstract Showing 60% ORR, 7.2‑mo mPFS for FID-007 plus Cetuximab - TradingView

May 21, 2026

May 21, 2026

Fulgent (NASDAQ: FLGT) reports 60% ORR in Phase 2 FID-007 cancer trial - Stock Titan

May 21, 2026

May 20, 2026

Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire

May 20, 2026

May 19, 2026

Fulgent Genetics targets wider engagement at APG2026 San Diego exhibit fair - Traders Union

May 19, 2026

May 19, 2026

FLGT Stock Chart | FULGENT GENETICS INC (NASDAQ:FLGT) - ChartMill

May 19, 2026

May 18, 2026

Fulgent Genetics (FLGT) director receives stock units and 8,426-share option grant - Stock Titan

May 18, 2026

May 18, 2026

Fulgent Genetics (NASDAQ: FLGT) director receives 11,117 RSUs - Stock Titan

May 18, 2026

May 18, 2026

Fulgent Genetics (NASDAQ: FLGT) director awarded 11,117 restricted stock units - Stock Titan

May 18, 2026

May 17, 2026

Fulgent Genetics (FLGT) price target decreased by 28.85% to 18.87 - MSN

May 17, 2026

May 14, 2026

Fulgent Genetics Shareholders Approve New 2026 Equity Plan - TipRanks

May 14, 2026

May 14, 2026

Fulgent Genetics (NASDAQ: FLGT) wins stockholder approval for 2026 equity plan - Stock Titan

May 14, 2026

May 14, 2026

ETFs Investing in Fulgent Genetics, Inc. Stocks - TradingView

May 14, 2026

May 13, 2026

Responsive Playbooks and the FLGT Inflection - Stock Traders Daily

May 13, 2026

May 12, 2026

Fulgent Genetics infertility test panels broaden to cover over 140 genes for females and 160 for males - Traders Union

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

LA500 2026: Ming Hsieh - Los Angeles Business Journal

May 11, 2026

May 09, 2026

Fulgent Genetics (NASDAQ:FLGT) Stock Passes Below Fifty Day Moving AverageHere's Why - MarketBeat

May 09, 2026

May 09, 2026

Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Wall Street Zen - MarketBeat

May 09, 2026

May 08, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail

May 08, 2026

May 07, 2026

Number of shareholders of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView

May 07, 2026

May 07, 2026

Fulgent (FLGT) Q1 2026 Earnings Transcript - AOL.com

May 07, 2026

May 06, 2026

SEC EDGAR Submission 0000950170-25-062257 - SEC.gov

May 06, 2026

May 05, 2026

How many employees work at Fulgent Therapeutics? - Revelio Labs

May 05, 2026

May 05, 2026

Foundation Medicine links with Fulgent Genetics to offer new gene test - Fierce Biotech

May 05, 2026

May 04, 2026

Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics - BioSpace

May 04, 2026

May 04, 2026

PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics - Business Wire

May 04, 2026

May 02, 2026

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2026 Earnings Call Transcript - Insider Monkey

May 02, 2026

May 02, 2026

Fulgent Q1 2026 slides: revenue misses amid customer loss, therapy data shines - Investing.com Nigeria

May 02, 2026

May 02, 2026

Fulgent Genetics Reports Q1 2026 Results: $71M Revenue, Stock Buyback, Updated Guidance and Progress in Cancer Therapeutics - Minichart

May 02, 2026

May 02, 2026

Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Na - GuruFocus

May 02, 2026

May 01, 2026

Understanding the Setup: (FLGT) and Scalable Risk - Stock Traders Daily

May 01, 2026

May 01, 2026

Fulgent Genetics, Inc. Q1 2026 SEC 10-Q Filing: Financial Statements, Company Information, and Risk Disclosure - Minichart

May 01, 2026

May 01, 2026

Fulgent Genetics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 01, 2026

May 01, 2026

Is Fulgent Genetics (FLGT) 38.5% Undervalued After Q1 2026? Reve - GuruFocus

May 01, 2026

May 01, 2026

Fulgent outlines $350M 2026 revenue outlook following Bako/StrataDx acquisition - MSN

May 01, 2026

May 01, 2026

Fulgent Genetics, Inc. (FLGT) reports Q1 loss, beats revenue estimates - MSN

May 01, 2026

May 01, 2026

Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 01, 2026

May 01, 2026

Fulgent Genetics Posts Q1 Loss, Reaffirms 2026 Outlook - TipRanks

May 01, 2026

May 01, 2026

Fulgent Genetics 1Q 2026: Revenue $71.1M, Net loss $(24.8)M, EPS $(0.80) — 10-Q Summary - TradingView

May 01, 2026

May 01, 2026

Fulgent Genetics Q1 Earnings Call Highlights - MarketBeat

May 01, 2026

May 01, 2026

Earnings call transcript: Fulgent Genetics disappoints with Q1 2026 results By Investing.com - Investing.com South Africa

May 01, 2026

May 01, 2026

Fulgent Reports First Quarter 2026 Financial Results - The National Law Review

May 01, 2026

May 01, 2026

Fulgent Genetics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 01, 2026